ðŠ ã³ããçŠãã«ã¡ã«ãŒã³ã®5æ³æªæºå ã®ãã©ãªã¢å ±åæ°ã«äžãã圱é¿ãšã¯ïŒç ç©¶çµæããèŠããŠããããš
æ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã®ãã³ãããã¯ã¯ãäžçäžã®äººã ã®ç掻ã«ç倧ãªåœ±é¿ãäžããŸãããç¹ã«å»çã·ã¹ãã ã¯å€§ããªæ··ä¹±ã«çŽé¢ããCOVID-19以å€ã®ç æ°ãžã®å¯Ÿå¿ã«ã圱é¿ãåãã ããšã¯æ³åã«é£ããããŸãããã¢ããªã«å€§éžã®åœã ã§ã¯ããã©ãªã¢ãäŸç¶ãšããŠåã©ããã¡ã®åœãè ããäž»èŠãªç æ°ã®äžã€ã§ãããã³ããçŠããã®ãã©ãªã¢å¯Ÿçã«ã©ã®ãããªåœ±é¿ãäžããã®ãããã®å®æ ã¯ååã«è§£æãããŠããŸããã§ããã
ä»åã玹ä»ããç ç©¶ã¯ãã«ã¡ã«ãŒã³ãèå°ã«ãã³ããçŠã5æ³æªæºã®åã©ããã¡ã®ãã©ãªã¢å ±åæ°ã«ã©ã®ãããªåœ±é¿ãäžããã®ãã詳现ã«åæãããã®ã§ãããã®ç ç©¶ã¯ã屿©æã«ãããå ¬è¡è¡çã·ã¹ãã ã®è匱æ§ãšããã©ãªã¢å¯Ÿçã®ç¶ç¶æ§ã®éèŠæ§ãæµ®ã圫ãã«ããŠããŸãã
ð ç ç©¶ã®èæ¯ãšç®ç
ãã©ãªã¢ã¯ãèãåªä»ããææçã§ãç¹ã«ã¢ããªã«ã®ç±åž¯å°åã§å€ãèŠãããŸããã«ã¡ã«ãŒã³ã§ãã5æ³æªæºã®åã©ããã¡ã®ç æ°ãæ»äº¡ã®äž»èŠãªåå ãšãªã£ãŠããŸãããã©ãªã¢å¯Ÿçã«ã¯ã殺è«å€åŠçãããèåž³ã®é åžãå£ç¯æ§ãã©ãªã¢ååŠäºé²ïŒSMCïŒïŒâ»1ïŒããããŠè¿ éãªèšºæãšæ²»çãäžå¯æ¬ ã§ãã
ããããCOVID-19ãã³ãããã¯ã¯ãå»çæ©é¢ãžã®ã¢ã¯ã»ã¹ã劚ãããããã©ãªã¢å¯Ÿçããã°ã©ã ã®ç¶ç¶ãå°é£ã«ãããããå¯èœæ§ãææãããŠããŸããããã®ç ç©¶ã®ç®çã¯ãã«ã¡ã«ãŒã³ã«ããã5æ³æªæºå ã®ãã©ãªã¢å ±åæ°ã«å¯ŸããŠãCOVID-19ã«é¢é£ããæ··ä¹±ãã©ã®ãããªåœ±é¿ãäžããã®ãããåœå šäœããã³å°åå¥ã«æšå®ããããšã§ããã
â»1 å£ç¯æ§ãã©ãªã¢ååŠäºé²ïŒSMCïŒïŒãã©ãªã¢ã®æµè¡æã«ãåã©ããã¡ã«å®æçã«æãã©ãªã¢è¬ãæäžããããšã§ããã©ãªã¢ã®çºçãäºé²ããæŠç¥ã
ð¬ ç ç©¶æ¹æ³
ãã®ç ç©¶ã§ã¯ã2017幎1æãã2022幎12æãŸã§ã®æããšã®DHIS2ïŒâ»2ïŒç£èŠããŒã¿ãçšããŠããäžææç³»ååæïŒInterrupted Time Series; ITSïŒãïŒâ»3ïŒãšããçµ±èšææ³ãçšããããŸãããããã«ãããCOVID-19ãã³ãããã¯ãšãããäžæç¹ããããã©ãªã¢å ±åæ°ã®åŸåã«ã©ã®ãããªå€åããããããããåæããŸããã
å ·äœçã«ã¯ã2020幎3æïŒãã³ãããã¯ã®éå§ïŒãš2022幎1æïŒãã³ãããã¯ç¶æ³ã®å€åïŒã®2ã€ã®æç¹ãäžæç¹ãšããŠèšå®ããŸãããåæã§ã¯ãæããšã®å£ç¯æ§ã殺è«å€åŠçãããèåž³ïŒLLINïŒïŒâ»4ïŒã®é åžæŽ»åãå£ç¯æ§ãã©ãªã¢ååŠäºé²ïŒSMCïŒæŽ»åãå°å ç§å蚺çããããŠ1ã¶æåã®éæ°Žéãšãã£ãæ§ã ãªèŠå ãèæ ®ã«å ¥ããŸãããããã«ãããCOVID-19ã®åœ±é¿ãããæ£ç¢ºã«è©äŸ¡ããããšè©Šã¿ãŸããã
â»2 DHIS2ïŒDistrict Health Information Software 2ã®ç¥ãå€ãã®éçºéäžåœã§å©çšãããŠãããä¿å¥å»çããŒã¿ãåéã»åæããããã®æ
å ±ã·ã¹ãã ã
â»3 äžææç³»ååæïŒITSïŒïŒç¹å®ã®ä»å
¥ïŒããã§ã¯COVID-19ãã³ãããã¯ïŒããæéçµéã«äŒŽãããŒã¿ïŒããã§ã¯ãã©ãªã¢å ±åæ°ïŒã®ãã¬ã³ãã«ã©ã®ãããªåœ±é¿ãäžããããçµ±èšçã«åæããææ³ã
â»4 殺è«å€åŠçãããèåž³ïŒLLINïŒïŒèãå¯ãä»ããªãããŸãã¯æ®ºã广ã®ããæ®ºè«å€ãå å·¥ãããèåž³ããã©ãªã¢äºé²ã®äž»èŠãªææ®µã®äžã€ã
ð äž»èŠãªç ç©¶çµæ
ãã®ç ç©¶ã§æããã«ãªã£ãäž»èŠãªãã€ã³ãã¯ä»¥äžã®éãã§ãã
| é ç® | çµæã®æŠèŠ |
|---|---|
| 2020幎3æã®å€åïŒãã³ãããã¯åæïŒ | ãã©ãªã¢å ±åæ°ã¯ããã³ãããã¯ä»¥åã®åŸåãšæ¯èŒããŠå³åº§ã«36.9%æžå°ããŸããïŒIRR = 0.631ïŒâ»5ïŒïŒãããã¯ãå»çæ©é¢ãžã®ã¢ã¯ã»ã¹ãé»å®³ãããããå ±åã·ã¹ãã ãæ©èœããªããªã£ãå¯èœæ§ã瀺åããŠããŸãã |
| ãã®åŸã®åŸåïŒ2020幎3æä»¥éïŒ | æåã®æžå°åŸãå ±åæ°ã¯æ¯æ3.1%ã®å²åã§å¢å ããåŸåãèŠãããŸããïŒIRR = 1.031ïŒãããã¯ããã³ãããã¯åæã®æ··ä¹±ããåŸã ã«å埩ããŠãã£ãããšã瀺åããŠããŸãã |
| 2022幎1æã®å€å | 2床ç®ã®ãäžæç¹ãïŒ2022幎1æïŒã§ã¯ãå ±åæ°ã®ã¬ãã«ãåŸåã«ææãªå€åã¯èŠãããŸããã§ãããããã¯ããã®ææã«ã¯å»çã·ã¹ãã ãžã®åœ±é¿ãéå®çã§ãã£ããããã§ã«å埩åºèª¿ã«ãã£ãããšã瀺åããŸãã |
| 殺è«å€åŠçèåž³ïŒLLINïŒã®å¹æ | 殺è«å€åŠçèåž³ã®é åžæŽ»åã¯ããã©ãªã¢å ±åæ°ã®æžå°ãšéçžé¢ããŠããŸããïŒIRR = 0.978ïŒãã€ãŸããèåž³ãé åžããããšãã©ãªã¢å ±åæ°ãæžãåŸåãããããã®äºé²å¹æã瀺åãããŸãã |
| ã«ãŠã³ã¿ãŒãã¡ã¯ãã¥ã¢ã«åæïŒâ»6ïŒã«ããæšå® | |
| 2020幎ïœ2021幎 | ããã³ããçŠããªãã£ãå Žåã«æ¯ã¹ãŠã69,708ä»¶ã®ãã©ãªã¢å ±åãäžè¶³ããŠãããšæšå®ãããŸãããããã¯ããã³ãããã¯åæã®å ±åæŒããå蚺æ§ãã®æ·±å»ãã瀺ããŠããŸãã |
| 2022幎 | äžæ¹ã2022幎ã«ã¯74,831ä»¶ã®å ±åãéå°ã§ãã£ããšæšå®ãããŸãããããã¯ããã³ãããã¯åæã«èšºæã»æ²»çãããªãã£ãçäŸãé ããŠå ±åããããããããã¯å»çã¢ã¯ã»ã¹ãå埩ããããšã§å ±åæ°ãå¢å ããå¯èœæ§ã瀺åããŠããŸãã |
| å°åå·® | å°åã«ãã£ãŠåœ±é¿ã¯å€§ããç°ãªããç¹ã«äžå€®å°åïŒCentreïŒã§46.7%æžãæ±éšå°åïŒEastïŒã§54.4%æžãšãåæã®æžå°ãèããå°åããããŸãããããã¯ãå°åããšã®å»çäœå¶ããã³ãããã¯ã®åœ±é¿ã®åããããã®éããåæ ããŠãããšèããããŸãã |
â»5 IRRïŒIncidence Rate RatioïŒïŒçºççæ¯ãããã§ã¯ãä»å
¥ïŒãã³ãããã¯ïŒåŸã«ãã©ãªã¢å ±åæ°ãã©ã®çšåºŠå€åããããç€ºãææšã1æªæºã§ããã°æžå°ã1ãã倧ãããã°å¢å ã瀺ãã
â»6 ã«ãŠã³ã¿ãŒãã¡ã¯ãã¥ã¢ã«åæïŒããç¹å®ã®ä»å
¥ïŒããã§ã¯ã³ããçŠïŒããªãã£ããã©ããªã£ãŠãããããšããä»®æ³çãªç¶æ³ãšæ¯èŒããããšã§ãä»å
¥ã®çã®åœ±é¿ãæšå®ããåæææ³ã
ð¡ ç ç©¶çµæããèŠããŠããããšïŒèå¯ïŒ
ãã®ç ç©¶çµæã¯ãCOVID-19ãã³ãããã¯ãã«ã¡ã«ãŒã³ã®5æ³æªæºå ã®ãã©ãªã¢å ±åã·ã¹ãã ã«æ·±å»ãªåœ±é¿ãäžããããšãæç¢ºã«ç€ºããŠããŸãã
ãŸãããã³ãããã¯åæã«ãã©ãªã¢å ±åæ°ãå€§å¹ ã«æžå°ããããšã¯ãå»çæ©é¢ãžã®ã¢ã¯ã»ã¹ãå¶éããããã人ã ãåèšºãæ§ãããããå¯èœæ§ã瀺åããŠããŸãããŸããå»çã¹ã¿ãããCOVID-19察å¿ã«è¿œãããããšã§ããã©ãªã¢ã®èšºæãå ±åæ¥åãæ»ã£ãããšãèããããŸãããã®æéã«èšºæã»æ²»çãããªãã£ããã©ãªã¢çäŸã倿°ååšããå¯èœæ§ããããããã¯åã©ããã¡ã®å¥åº·ã«ãšã£ãŠéåžžã«å±éºãªç¶æ³ã§ãã£ããšèšããã§ãããã
ãã®åŸãå ±åæ°ãåŸã ã«å埩ãã2022幎ã«ã¯ãã³ãããã¯ããªãã£ãå Žåãããå ±åæ°ãå€ããªã£ããšããçµæã¯è峿·±ããã®ã§ããããã¯ããã³ãããã¯åæã«ãèŠéããããããã©ãªã¢çäŸããå»çã·ã¹ãã ãèœã¡çããåãæ»ããåŸã«èšºæã»å ±åãããå¯èœæ§ã瀺åããŠããŸãããããã¯ãå»çã¢ã¯ã»ã¹ãå埩ããããšã§ã以åãããå€ãã®çäŸãææãããããã«ãªã£ãã®ãããããŸããã
å°åã«ãã£ãŠåœ±é¿ã®å€§ããã«å·®ããã£ãããšãéèŠãªãã€ã³ãã§ããããã¯ãå°åããšã®å»çè³æºã®å·®ãCOVID-19ã®æµè¡ç¶æ³ããããã¯ãã©ãªã¢å¯Ÿçããã°ã©ã ã®å®æœç¶æ³ã®éãã圱é¿ããå¯èœæ§ããããŸããç¹å®ã®å°åã§ããæ·±å»ãªåœ±é¿ãèŠãããããšã¯ã屿©å¯Ÿå¿ã«ãããŠå°åããšã®ç¶æ³ã«å¿ãããã现ãããªå¯Ÿçãå¿ èŠã§ããããšã瀺åããŠããŸãã
ãŸããæ®ºè«å€åŠçèåž³ã®é åžããã©ãªã¢å ±åæ°ã®æžå°ãšé¢é£ããŠããããšã¯ã屿©æã«ãããŠãåºæ¬çãªãã©ãªã¢äºé²çã®ç¶ç¶ãããã«éèŠã§ããããå確èªãããçµæã§ãã
ð€ ç§ãã¡ã®ç掻ãžã®ç€ºåãšã¢ããã€ã¹
ãã®ç ç©¶çµæã¯ãé ãåœã®è©±ãšããŠçä»ãããããã®ã§ã¯ãããŸãããç§ãã¡èªèº«ã®ç掻ããå°æ¥èµ·ãããã屿©ãžã®åãã«ãéããéèŠãªæèšãå«ãã§ããŸãã
- 屿©æã§ãå»çæ©é¢ã®å蚺ããããããªãïŒ ãã³ãããã¯ã®ãããªå±æ©çç¶æ³äžã§ã¯ãå»çæ©é¢ãžã®ã¢ã¯ã»ã¹ãå°é£ã«ãªã£ãããå蚺ããããã£ããããããšããããŸãããããããã©ãªã¢ã®ãããªé節ãªç æ°ã¯ãæ©æèšºæã»æ©ææ²»çãåœãæããŸããçºç±ãªã©ã®çç¶ãããå Žåã¯ãé©åãªææå¯Ÿçãè¬ããäžã§ãå»çæ©é¢ã«çžè«ããããšãéèŠã§ãã
- åºæ¬çãªææçäºé²çã®ç¶ç¶ïŒ ãã©ãªã¢ã®äºé²ã«ã¯èåž³ãæå¹ã§ããããã«ãä»ã®ææçã«ãææŽãããã¹ã¯ççšãææ°ãªã©ãåºæ¬çãªäºé²çãéåžžã«éèŠã§ãã屿©æã§ãã£ãŠãããããã®å¯Ÿçãç¶ç¶ããããšããèªåèªèº«ãšåšå²ã®äººã ãå®ãããšã«ã€ãªãããŸãã
- å ¬è¡è¡çã·ã¹ãã ã®åŒ·åãæ¯æŽããïŒ å±æ©æã«ãæ©èœãç¶ãã匷éãªå ¬è¡è¡çã·ã¹ãã ã¯ãç§ãã¡ã®ç€ŸäŒã«ãšã£ãŠäžå¯æ¬ ã§ããåœéååãæ¯æŽãéããŠãéçºéäžåœã®å ¬è¡è¡çã·ã¹ãã 匷åã«è²¢ç®ããããšã¯ãå°çå šäœã®å¥åº·ãå®ãããšã«ã€ãªãããŸãã
- æ£ç¢ºãªæ å ±åéãšå·éãªå€æïŒ 屿©æã«ã¯æ§ã ãªæ å ±ãé¯ç¶ããŸããä¿¡é Œã§ããæ å ±æºããæ£ç¢ºãªæ å ±ãåŸãŠãå·éã«å€æããããšããé©åãªè¡åããšãäžã§äžå¯æ¬ ã§ãã
ð§ ç ç©¶ã®éçãšä»åŸã®èª²é¡
ãã®ç ç©¶ã¯éèŠãªç¥èŠããããããŸããããããã€ãã®éçãååšããŸãã
- å ±åããŒã¿ã«åºã¥ãåæïŒ æ¬ç ç©¶ã¯ãå®éã«èšºæã»å ±åããããã©ãªã¢çäŸã®ããŒã¿ã«åºã¥ããŠããŸãããããããã³ãããã¯äžã«å蚺æ§ãããã£ããã蚺æãè¡ãããªãã£ããããçäŸã¯ããŒã¿ã«åæ ãããŸããããã®ãããå®éã®ãã©ãªã¢çœ¹æ£çã®å€åãšã¯ç°ãªãå¯èœæ§ããããŸãã
- DHIS2ããŒã¿ã®è³ªïŒ ããŒã¿ã®åéã»å ±åã·ã¹ãã ã§ããDHIS2ã®ããŒã¿ã®è³ªããåæçµæã«åœ±é¿ãäžããå¯èœæ§ããããŸãã
- ä»ã®èŠå ã®åœ±é¿ïŒ COVID-19ãã³ãããã¯ä»¥å€ã«ããçµæžç¶æ³ã®å€åãçŽäºãèªç¶çœå®³ãªã©ããã©ãªã¢å ±åæ°ã«åœ±é¿ãäžããèŠå ã¯å€æ°ååšããŸãããããã®èŠå ãå®å šã«æé€ããŠCOVID-19ã®åœ±é¿ã®ã¿ãæœåºããããšã¯å°é£ã§ãã
ä»åŸã®èª²é¡ãšããŠã¯ãå ±åæ°ã®å€åãå®éã®ãã©ãªã¢çœ¹æ£çãæ»äº¡çã«ã©ã®ããã«åœ±é¿ããã®ãããããçŽæ¥çãªããŒã¿ãçšããŠæ€èšŒããããšããããŠå°åããšã®è©³çްãªç€ŸäŒçµæžçèŠå ãå»çã¢ã¯ã»ã¹ã®ç¶æ³ãèæ ®ããåæãé²ããããšãæããããŸãã
ãŸãšã
ã«ã¡ã«ãŒã³ã«ããã5æ³æªæºå ã®ãã©ãªã¢å ±åæ°ã¯ãCOVID-19ãã³ãããã¯ã®åæã«å€§å¹ ãªæžå°ãèŠããŸãããããã®åŸã¯åŸã ã«å埩ããå°åã«ãã£ãŠãã®åœ±é¿ã®å€§ããã«å€§ããªå·®ãããããšãæããã«ãªããŸããããã®ç ç©¶ã¯ã屿©æã«ãããŠããã©ãªã¢å¯Ÿçããã°ã©ã ãç¶ç¶ããããšã®éèŠæ§ããããŠå°åããšã®ç¶æ³ã«å¿ããæè»ãªå¯Ÿå¿ãå¯èœã«ããã質ã®é«ãç£èŠã·ã¹ãã ã®å¿ èŠæ§ã匷ã瀺åããŠããŸãããã³ãããã¯ã®ãããªäºæãã¬äºæ ã«çŽé¢ããŠããåã©ããã¡ã®åœãå®ãããã®å»çãµãŒãã¹ãéåããªããããåœé瀟äŒå šäœã§ååããå ¬è¡è¡çã·ã¹ãã ã®åŒ·åã«åãçµãããšãæ±ããããŠããŸãã
ð é¢é£ãªã³ã¯é
- äžçä¿å¥æ©é¢ïŒWHOïŒ
- åçåŽåç ææçæ å ±
- åœç«ææçç ç©¶æ
- åœå¢ãªãå»åž«å£ ãã©ãªã¢
- ãŠãã»ã ãã©ãªã¢
- PubMedïŒè«ææ€çŽ¢ããŒã¿ããŒã¹ïŒ
æžèªæ å ±
| DOI | 10.1186/s12936-026-05958-1 |
|---|---|
| PMID | 42218487 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42218487/ |
| çºè¡å¹Ž | 2026 |
| èè å | Mekontchou Léa Melataguia, Nguefack-Tsague Georges, Sonegueng Alice Verdiane Koudjou, Deffo Paul Yvan, Sepde Emtom, Samadoulougou Sékou |
| èè æå± | School of Public Health, Université Libre de Bruxelles, Brussels, Belgium. leamelataguia7@gmail.com.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.; Université de Picardie Jules Verne, Amiens, France.; HEADA Cameroon, Yaoundé, Cameroon.; Directorate for Disease, Epidemic and Pandemic Control, Ministry of Public Health, Yaoundé, Cameroon.; School of Public Health, Université Libre de Bruxelles, Brussels, Belgium. |
| éèªå | Malar J |